Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.91
0.163.37%
At close: -
$4.91
0.000.00%
After Hours: Dec 20, 4:03 PM EDT
Comments
Loading...
OptimizeRx (NASDAQ:OPRX) Stock, Analyst Ratings, Price Targets, Forecasts
OptimizeRx Corp has a consensus price target of $20.71 based on the ratings of 12 analysts. The high is $66 issued by Roth Capital on May 5, 2022. The low is $5 issued by Barclays on November 14, 2024. The 3 most-recent analyst ratings were released by Stephens & Co., JMP Securities, and RBC Capital on December 20, 2024, November 14, 2024, and November 14, 2024, respectively. With an average price target of $6.83 between Stephens & Co., JMP Securities, and RBC Capital, there's an implied 39.17% upside for OptimizeRx Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
JMP Securities
RBC Capital
Roth MKM
Stifel
1calculated from analyst ratings
Analyst Ratings for OptimizeRx
Data brought to you by Benzinga APIs
FAQ
What is the target price for OptimizeRx (OPRX) stock?
The latest price target for OptimizeRx (NASDAQ:OPRX) was reported by Stephens & Co. on December 20, 2024. The analyst firm set a price target for $5.50 expecting OPRX to rise to within 12 months (a possible 12.02% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OptimizeRx (OPRX)?
The latest analyst rating for OptimizeRx (NASDAQ:OPRX) was provided by Stephens & Co., and OptimizeRx initiated their equal-weight rating.
When was the last upgrade for OptimizeRx (OPRX)?
There is no last upgrade for OptimizeRx
When was the last downgrade for OptimizeRx (OPRX)?
There is no last downgrade for OptimizeRx.
When is the next analyst rating going to be posted or updated for OptimizeRx (OPRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptimizeRx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptimizeRx was filed on December 20, 2024 so you should expect the next rating to be made available sometime around December 20, 2025.
Is the Analyst Rating OptimizeRx (OPRX) correct?
While ratings are subjective and will change, the latest OptimizeRx (OPRX) rating was a initiated with a price target of $0.00 to $5.50. The current price OptimizeRx (OPRX) is trading at is $4.91, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.